{"id":"W3094115567","doi":"10.2217/cer-2020-0122","title":"Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ofatumumab; Medicine; Natalizumab; Ocrelizumab; Alemtuzumab; Multiple sclerosis; Internal medicine; Meta-analysis; Oncology; Disease; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01427486,0.002553537,0.01217047,0.002650668,0.000485606,0.002248209,0.00160929,0.002162539,0.00303664],"category_scores_gemma":[0.02141478,0.001022174,0.03418383,0.002487102,0.0005939824,0.001176792,0.001202477,0.002173841,0.0001948092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001263293,"about_ca_system_score_gemma":0.0009700444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004871718,"about_ca_topic_score_gemma":0.006111524,"domain_scores_codex":[0.989732,0.006984344,0.001060744,0.001289685,0.0006557409,0.0002775184],"domain_scores_gemma":[0.9845579,0.01233083,0.001649058,0.000637182,0.0005676257,0.0002574509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01979701,0.00005479672,0.007215757,0.023075,0.9433246,0.00006521001,0.00002145762,0.001212417,0.000258418,0.0001085409,0.000247942,0.004618879],"study_design_scores_gemma":[0.003531481,0.000584109,0.004557086,0.00104373,0.9888388,0.00004175346,0.00001282329,0.0006717382,0.0001149851,0.0001796076,0.0004116883,0.00001230943],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1200093,0.8717339,0.00323954,0.0007487991,0.0007628895,0.0005396884,0.001709766,0.0001047001,0.00115146],"genre_scores_gemma":[0.8829942,0.110162,0.003274258,0.0007752284,0.000469818,0.0006541588,0.00109454,0.0000476789,0.0005281781],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01427486,"threshold_uncertainty_score":0.07549363,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6942617178013222,"score_gpt":0.5352789439256699,"score_spread":0.1589827738756523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}